bibliographicCitation |
Chen S, Yu Q, Jiang W, Lu Y, Zhao Y, Wang H. Rechallenge with EGFR-TKI after failure of immunotherapy is considered an effective treatment for advanced lung adenocarcinoma patients with EGFR exon 19 deletion: a case report. Front Med (Lausanne). 2023;10():1168220. PMID: 37457583; PMCID: PMC10339383. |